11 January 2023
Benchmark Holdings plc
("Benchmark" or "the Company")
Posting of Notice of AGM
Benchmark, the aquaculture health, nutrition and genetics business, announces that further to the announcement made on 1 December 2022, its notice of the 2023 Annual General Meeting ("AGM") and related form of proxy have been posted to shareholders today. A copy of the AGM notice is available to download from our investors' website, www.benchmarkplc.com/investors/.
The AGM will be held on 16 February 2023 at 3.00p.m. (London time) at the offices of Travers Smith LLP, 10 Snow Hill, London, EC1A 2AL.
A copy of the AGM notice and an accompanying form of proxy have also been sent to those beneficial holders whose ordinary shares are registered in the name of Euroclear Nominees as custodian for DNB Bank ASA ("DNB") and are held by DNB as nominee in The Norwegian Central Securities Depository (Euronext Securities Oslo) ("ESO shareholders"). Details of how ESO shareholders can ensure their vote is cast at the AGM are set out in the AGM notice and the accompanying form of proxy for ESO shareholders.
The Board is keen to encourage engagement with shareholders. In order to facilitate this, if you are unable to attend but would like to ask the Board a question on the business of the AGM, please submit your questions by email to AGM@bmkholdings.com, so as to arrive by 3.00p.m. (London time) on 14 February 2023. Responses will be made via return email or published on our investors' website at www.benchmarkplc.com/investors/, as deemed appropriate by the Board of Directors.
Enquiries
|
|
About Benchmark
Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering mission-critical products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare. Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark addresses the major aquaculture species - salmon, shrimp, sea bass and bream, and tilapia, in all the aquaculture regions around the world.
Find out more at www.benchmarkplc.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
